To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Auron Therapeutics has raised a $27 million Series B ...
Kate Yen is the founder and CEO of Auron Therapeutics. From the Boston Business Journal. Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results